O83464 AF NFT

Elongation factor G 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicqetlozxaifau5ozyzuqs7pqc25xch4hmuvnw2kicqylgymp47d4/metadata.json
IPFS of structure file: 
bafybeihvpvcfan4tstzulsbijl7ef6lc7yu2m6l6dtokv3c2cvzpvs6xz4/AF-O83464-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x46EfCa788d03A3e879DAcDb96552AB8Bbc7e20b3
First NFT owner address (bech32): 
genesis1gmhu57ydqw37s7w6ekuk254t3w78ug9ndfc7sx
Current NFT ID #111100 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
111100
Accession (UniProt):
O83464
Name::
Elongation factor G 2
Experimental Method:
Predicted structure
Sequence source:
TREPONEMA PALLIDUM (STRAIN NICHOLS)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT O83464 research and analysis (ICN3D with VR)

FASTA sequences

>sp|O83464|EFG2_TREPA Elongation factor G 2 OS=Treponema pallidum (strain Nichols) OX=243276 GN=fusB PE=3 SV=1 MRQQQMRNIGIMAHVDAGKTTTTERMLFYTGKIHRMGEIDDGATTMDWMVQEQERGITIQSAATTVRWREVDITIIDTPGHVDFTAEVERALRVLDGVVVVLCAVGRVQPQTETVWYQADRYDIPRVCFVNKMDRIGADFFSVLDQVHNKFGIDAVALQIPIGSGTSFEGVIDLITMKEIFWDAASSGEQMEYRPIQSARIAQAREAREKMLDVISIYSDEVTECVLAGEHVPVQLLHAEIRKAVRERRYVPFLCGSSRHNLGVQPLLDAVVEYLPAPQERKAVEGFHVQKKEPVFIAPTAEGPLLALVFKIQYEREAGLLCYVRMYSGKLRTGDSIVNIGKKKRERVYRILRMHSNKSETVECIQAGDIAVIVGLKSAQTGDSVGDGSCPVVLESMHFPEPVISVSLEPMDASSRDKLQETLGILSREDPTFSVREDAETGQLLISGMGELHLDVLTTRMREDFNVQVRVGKPHVTYRESIRKTVERTLRVQRVIGGKEYMAGLTLRVEARKRGAGNEFFCQVKELRGTVCTAHTAPAEIIGAVEHAIRGAWDGGIQSGYPCVDVGVHLLSVEYQELTSSPFIFEAAAVQAFGEACVAAEPYVLEPIMSVELSCAQENVGDVMNVIIQRGGIILGMDSKHGRELVHAQAPMKKMFGFSTDVRSASRGGASFTMRFSHFESCA